Literature DB >> 7632695

Berenil [1,3-bis(4'-amidinophenyl)triazene] binding to DNA duplexes and to a RNA duplex: evidence for both intercalative and minor groove binding properties.

D S Pilch1, M A Kirolos, X Liu, G E Plum, K J Breslauer.   

Abstract

Berenil is an antitrypanosomal agent that binds to nucleic acid duplexes. The generally accepted mode of berenil binding is via complexation into the minor groove of AT-rich domains of DNA double helices. We find that berenil can bind to RNA as well as DNA duplexes, while exhibiting properties characteristic of both intercalation as well as minor groove binding. More specifically, we use spectroscopic, calorimetric, and hydrodynamic techniques to characterize berenil binding to four DNA duplexes and to one RNA duplex. Our results reveal the following features: (i) Berenil binding to the poly[d(A-T)]2, poly(dA).poly(dT), poly[d(I-C)]2, poly[d(G-C)]2, and poly(rA).poly(rU) duplexes exhibits intercalative as well as minor groove binding characteristics. (ii) The apparent "site sizes" associated with berenil binding to these five duplexes range from 1 to 13 base pairs per bound berenil and depend, in part, on the host duplex. One of the site sizes common to all five duplexes is consistent with berenil binding to the minor groove. (iii) The apparent berenil binding affinity follows the hierarchy: poly(dA).poly(dT) > poly-[d(A-T)]2 approximately poly[d(I-C)]2 >> poly(rA).poly(rU) > poly[d(G-C)]2. (iv) Viscometric data reveal properties characteristic of a significant contribution from an intercalative mode of binding when berenil interacts with the poly[d(A-T)]2, poly[d(I-C)]2, poly[d(G-C)]2, and poly(rA).poly(rU) duplexes, while revealing an apparent nonintercalative mode when the drug binds to the poly(dA).poly(dT) duplex. (v) Berenil binding unwinds negative supercoils in the pBR322 plasmid, an observation consistent with an intercalative mode of binding to duplex DNA. (vi) Salt-dependent melting data suggest that both positively charged amidino groups of berenil participate in the complexation of the drug to the poly[d(I-C)]2, poly[d(A-T)]2, poly(dA).poly(dT), and poly(rA).poly(rU) duplexes, while also suggesting that the binding event is site-specific. In the aggregate, our results suggest that, in contrast to the conventional wisdom, berenil can exhibit intercalative as well as minor groove binding properties when it binds to both DNA and RNA duplexes, while also exhibiting a preference for DNA duplexes with unobstructed minor grooves. We comment on the potential correlation between drugs, such as berenil, that exhibit "mixed" binding motifs and those that express anticancer activity via inhibition of topoisomerase I activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632695     DOI: 10.1021/bi00031a019

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Revisiting the association of cationic groove-binding drugs to DNA using a Poisson-Boltzmann approach.

Authors:  Marcia O Fenley; Robert C Harris; B Jayaram; Alexander H Boschitsch
Journal:  Biophys J       Date:  2010-08-04       Impact factor: 4.033

2.  Break in the heat capacity change at 303 K for complex binding of netropsin to AATT containing hairpin DNA constructs.

Authors:  Matthew W Freyer; Robert Buscaglia; Amy Hollingsworth; Joseph Ramos; Meredith Blynn; Rachael Pratt; W David Wilson; Edwin A Lewis
Journal:  Biophys J       Date:  2007-01-19       Impact factor: 4.033

3.  Electron photodetachment dissociation of DNA anions with covalently or noncovalently bound chromophores.

Authors:  Valérie Gabelica; Frédéric Rosu; Edwin De Pauw; Rodolphe Antoine; Thibault Tabarin; Michel Broyer; Philippe Dugourd
Journal:  J Am Soc Mass Spectrom       Date:  2007-08-22       Impact factor: 3.109

Review 4.  Antiparasitic compounds that target DNA.

Authors:  W David Wilson; Farial A Tanious; Amanda Mathis; Denise Tevis; James Edwin Hall; David W Boykin
Journal:  Biochimie       Date:  2008-03-04       Impact factor: 4.079

5.  Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.

Authors:  Yanfei Qi; Juan Zhang; Colleen T Cole-Jeffrey; Vinayak Shenoy; Andrew Espejo; Mina Hanna; Chunjuan Song; Carl J Pepine; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2013-08-19       Impact factor: 10.190

6.  Subcellular in vivo 1H MR spectroscopy of Xenopus laevis oocytes.

Authors:  Seung-Cheol Lee; Jee-Hyun Cho; Daniel Mietchen; Young-Sook Kim; Kwan Soo Hong; Chulhyun Lee; Dongmin Kang; Ki Deok Park; Byong-Seok Choi; Chaejoon Cheong
Journal:  Biophys J       Date:  2005-12-16       Impact factor: 4.033

7.  The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroism.

Authors:  C Bailly; P Colson; C Houssier; F Hamy
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

8.  Probing drug-DNA interactions using super-resolution force spectroscopy.

Authors:  Haina Jia; Te-Wei Tsai; Shoujun Xu
Journal:  Appl Phys Lett       Date:  2018-11-06       Impact factor: 3.791

9.  Linker dependent intercalation of bisbenzimidazole-aminosugars in an RNA duplex; selectivity in RNA vs. DNA binding.

Authors:  Nihar Ranjan; Dev P Arya
Journal:  Bioorg Med Chem Lett       Date:  2016-10-27       Impact factor: 2.823

10.  Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.

Authors:  Vinayak Shenoy; Altin Gjymishka; Yagna P Jarajapu; Yanfei Qi; Aqeela Afzal; Katya Rigatto; Anderson J Ferreira; Rodrigo A Fraga-Silva; Patrick Kearns; Jane Yellowlees Douglas; Deepmala Agarwal; Kamal K Mubarak; Chastity Bradford; William R Kennedy; Joo Y Jun; Anandharajan Rathinasabapathy; Erin Bruce; Dipankar Gupta; Arturo J Cardounel; J Mocco; Jawaharlal M Patel; Joseph Francis; Maria B Grant; Michael J Katovich; Mohan K Raizada
Journal:  Am J Respir Crit Care Med       Date:  2013-01-31       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.